Literature DB >> 15722028

Establishment of conventional and fluorescence resonance energy transfer-based real-time PCR assays for detection of pathogenic New World arenaviruses.

Simon Vieth1, Christian Drosten, Remi Charrel, Heinz Feldmann, Stephan Günther.   

Abstract

BACKGROUND: Five of the known arenaviruses cause viral hemorrhagic fever in humans and are classified as biosafety level 4 pathogens. Four of the viruses, namely Junin, Guanarito, Machupo, and Sabia, belong to clade B of New World arenaviruses that also comprises the nonpathogenic viruses Tacaribe, Cupixi, and Amapari.
OBJECTIVES: To establish real-time reverse transcription (RT)-PCR assays for Junin and Guanarito virus based on fluorescence resonance energy transfer (FRET) probes, and a universal RT-PCR assay for all known clade B viruses with conventional read-out.
RESULTS: Conserved sequences in the nucleoprotein gene were chosen as target sites for primers and FRET probes. A common set of primers was designed for all three assays. The assays were based on one-step RT-PCR reagents and were optimised with respect to analytical sensitivity using synthetic RNA templates. The real-time PCR assays detected about 0.5 and 5TCID(50) of cell culture-derived Junin and Guanarito virus, respectively. The universal clade B PCR amplified cell culture-derived RNA of Junin, Guanarito, Machupo, and Sabia virus (5-500TCID(50) per reaction), as well as RNA of Tacaribe, Cupixi, and Amapari virus.
CONCLUSIONS: The PCR assays may be used as complementary diagnostic tests for pathogenic New World arenaviruses. The universal PCR assay could also be suitable for the detection of novel clade B arenaviruses in patients as well as in animal reservoirs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722028     DOI: 10.1016/j.jcv.2004.07.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  4 in total

1.  Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses.

Authors:  Mina Nakauchi; Shuetsu Fukushi; Masayuki Saijo; Tetsuya Mizutani; Agustín E Ure; Victor Romanowski; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

2.  Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.

Authors:  Ioannis Veliziotis; Alain Roman; Delphine Martiny; Gerlind Schuldt; Marc Claus; Nicolas Dauby; Sigi Van den Wijngaert; Charlotte Martin; Rakan Nasreddine; Claudia Perandones; Romain Mahieu; Corien Swaan; Serge Van Praet; Deborah Konopnicki; Maria A Morales; Denis Malvy; Etienne Stevens; Philippe Dechamps; Erika Vlieghe; Olivier Vandenberg; Stephan Günther; Michèle Gérard
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

Review 3.  Viral hemorrhagic fevers: current status of endemic disease and strategies for control.

Authors:  Dennis J Cleri; Anthony J Ricketti; Richard B Porwancher; Luz S Ramos-Bonner; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2006-06       Impact factor: 5.982

4.  A flexible format LAMP assay for rapid detection of Ebola virus.

Authors:  Laura C Bonney; Robert J Watson; Gillian S Slack; Andrew Bosworth; Nadina I Vasileva Wand; Roger Hewson
Journal:  PLoS Negl Trop Dis       Date:  2020-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.